Hwail Pharm Co Ltd
KOSDAQ:061250
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hwail Pharm Co Ltd
KOSDAQ:061250
|
KR |
|
China Sinostar Group Company Ltd
HKEX:485
|
HK |
|
Erdene Resource Development Corp
TSX:ERD
|
CA |
|
Madison Square Garden Sports Corp
NYSE:MSGS
|
US |
|
W
|
Wolters Kluwer NV
XMUN:WOSB
|
NL |
|
Avolta AG
OTC:DFRYF
|
CH |
|
Z
|
Zenova Group PLC
LSE:ZED
|
UK |
|
D
|
Directa SIM SpA
F:ZP7
|
IT |
|
I
|
International Container Terminal Services Inc
OTC:ICTEF
|
PH |
|
NEC Capital Solutions Ltd
TSE:8793
|
JP |
|
K
|
K-One Technology Bhd
KLSE:K1
|
MY |
|
G
|
GemVaxLink Co Ltd
KOSDAQ:064800
|
KR |
Dividends
Dividend Yield
Hwail Pharm Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Hwail Pharm Co Ltd
Payout Ratio
Hwail Pharm Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Hwail Pharm Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Hwail Pharm Co Ltd
| Average Annual Return | -19.19% |
| Standard Deviation of Annual Returns | 18.14% |
| Max Drawdown | -79% |
| Market Capitalization | 68.6B KRW |
| Shares Outstanding | 8 420 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Hwail Pharm Co Ltd's latest stock split occurred on May 4, 2026
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, Hwail Pharm Co Ltd traded at 943 per share. Afterward, the share price was about 9030.
The adjusted shares began trading on May 4, 2026. This was stock split number 4 in Hwail Pharm Co Ltd's history, following the previous one in Mar 17, 2021.